Between 2022 and 2032, the global multiple endocrine neoplasia market is expected to develop at a high CAGR of over 6.0%. The key force driving the worldwide multiple endocrine neoplasia market is rising consumption of multiple endocrine neoplasia drugs to alleviate symptoms and improve quality of life.Multiple endo.